LGWM
ABBV icon

Litman Gregory Wealth Management’s AbbVie ABBV Stock Holding History

Litman Gregory Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$27.9K Buy
+122
New +$27.8K ﹤0.01% 255
2023
Q4 		– Sell
-2,285
Closed -$341K – 120
2023
Q3 		$341K Buy
+2,285
New +$335K 0.04% 100
2020
Q1 		– Sell
-41
Closed -$4K – 165
2019
Q4 		$4K Buy
+41
New +$3.4K ﹤0.01% 175

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Litman Gregory Wealth Management's ABBV Position: Q4 2025 in Review

Litman Gregory Wealth Management opened a new position in AbbVie (ABBV) in Q4 2025: 122 shares worth $27.9K. The stake represents ﹤0.01% of the portfolio and ranks #255 among its holdings. This is a return to the name: Litman Gregory Wealth Management previously reported a position in ABBV as recently as Q3 2023.

Litman Gregory Wealth Management first reported a position in ABBV in Q4 2019 and has held it in 3 quarters since. The position peaked at $341K in Q3 2023. 4,171 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

  • Litman Gregory Wealth Management held 122 shares of AbbVie worth $27.9K as of Q4 2025.
  • AbbVie was a new Litman Gregory Wealth Management position in Q4 2025.
  • AbbVie made up ﹤0.01% of Litman Gregory Wealth Management's portfolio in Q4 2025, its #255 holding.
  • Litman Gregory Wealth Management first reported a position in AbbVie in Q4 2019 and has held it in 3 quarters since.
  • Litman Gregory Wealth Management's AbbVie position peaked at $341K in Q3 2023.
  • 4,171 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on Litman Gregory Wealth Management's 13F filing for Q4 2025, filed 12 Feb 2026.